| Cervical cancer in low and middle‑income countries R Hull, M Mbele, T Makhafola, C Hicks, SM Wang, RM Reis, R Mehrotra, ... Oncology letters 20 (3), 2058-2074, 2020 | 301 | 2020 |
| Artificial intelligence (AI) and big data in cancer and precision oncology Z Dlamini, FZ Francies, R Hull, R Marima Computational and structural biotechnology journal 18, 2300-2311, 2020 | 247 | 2020 |
| Breast cancer in low-middle income countries: abnormality in splicing and lack of targeted treatment options FZ Francies, R Hull, R Khanyile, Z Dlamini American journal of cancer research 10 (5), 1568, 2020 | 177 | 2020 |
| Colon cancer: genomics and apoptotic events C Rupnarain, Z Dlamini, S Naicker, K Bhoola Walter de Gruyter 385 (6), 449-464, 2004 | 151 | 2004 |
| The molecular mechanisms of oesophageal cancer ML McCabe, Z Dlamini International immunopharmacology 5 (7-8), 1113-1130, 2005 | 131 | 2005 |
| Genealogy, expression, and molecular mechanisms in apoptosis Z Dlamini, Z Mbita, M Zungu Pharmacology & therapeutics 101 (1), 1-15, 2004 | 120 | 2004 |
| Kallikrein and kinin receptor expression in inflammation and cancer K Bhoola, R Ramsaroop, J Plendl, B Cassim, Z Dlamini, S Naicker Walter de Gruyter 382 (1), 77-89, 2001 | 116 | 2001 |
| Molecular genetics of human cervical cancer: role of papillomavirus and the apoptotic cascade T Ledwaba, Z Dlamini, S Naicker, K Bhoola Walter de Gruyter 385 (8), 671-682, 2004 | 71 | 2004 |
| Translocator protein (TSPO) as a potential biomarker in human cancers NH Bhoola, Z Mbita, R Hull, Z Dlamini International journal of molecular sciences 19 (8), 2176, 2018 | 61 | 2018 |
| Upregulation of tissue kallikrein, kinin B1 receptor, and kinin B2 receptor in mast and giant cells infiltrating oesophageal squamous cell carcinoma Z Dlamini, KD Bhoola Journal of clinical pathology 58 (9), 915-922, 2005 | 58 | 2005 |
| African medicinal plants and their derivatives: Current efforts towards potential anti-cancer drugs M Mbele, R Hull, Z Dlamini Experimental and Molecular Pathology 103 (2), 121-134, 2017 | 56 | 2017 |
| Expression and function of retinoblastoma binding protein 6 (RBBP6) in human lung cancer LR Motadi, KD Bhoola, Z Dlamini Immunobiology 216 (10), 1065-1073, 2011 | 51 | 2011 |
| Colorectal cancer genetics, incidence and risk factors: in search for targeted therapies R Hull, FZ Francies, M Oyomno, Z Dlamini Cancer management and research, 9869-9882, 2020 | 50 | 2020 |
| Abnormalities in alternative splicing in diabetes: therapeutic targets Z Dlamini, F Mokoena, R Hull Journal of molecular endocrinology 59 (2), R93-R107, 2017 | 50 | 2017 |
| Molecular genetics and mechanisms of apoptosis in carcinomas of the lung and pleura: therapeutic targets LR Motadi, NL Misso, Z Dlamini, KD Bhoola International immunopharmacology 7 (14), 1934-1947, 2007 | 50 | 2007 |
| De-regulation of the RBBP6 isoform 3/DWNN in human cancers Z Mbita, M Meyer, A Skepu, M Hosie, J Rees, Z Dlamini Molecular and cellular biochemistry 362, 249-262, 2012 | 45 | 2012 |
| Human immunodeficiency virus-1 (HIV-1)-mediated apoptosis: new therapeutic targets Z Mbita, R Hull, Z Dlamini Viruses 6 (8), 3181-3227, 2014 | 43 | 2014 |
| Esophageal Cancer in African Blacks of KwaZulu Natal, South Africa Z Dlamini, K Bhoola Ethnicity & disease 15 (4), 786-789, 2005 | 36 | 2005 |
| The role of microRNAs in kidney disease S Mukhadi, R Hull, Z Mbita, Z Dlamini Non-coding RNA 1 (3), 192-221, 2015 | 33 | 2015 |
| Abnormalities in alternative splicing of apoptotic genes and cardiovascular diseases Z Dlamini, SC Tshidino, R Hull International journal of molecular sciences 16 (11), 27171-27190, 2015 | 33 | 2015 |
Rodney HullUniversity of Pretoria在 up.ac.za 的电子邮件经过验证
